Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-17-025044
Filing Date
2017-04-21
Accepted
2017-04-21 07:33:45
Documents
8
Period of Report
2017-04-21

Document Format Files

Seq Description Document Type Size
1 6-K a17-11632_16k.htm 6-K 43605
2 GRAPHIC g116321bei001.jpg GRAPHIC 85717
3 GRAPHIC g116321bei002.jpg GRAPHIC 117759
4 GRAPHIC g116321bei003.jpg GRAPHIC 109151
5 GRAPHIC g116321bei004.jpg GRAPHIC 130294
6 GRAPHIC g116321bei005.jpg GRAPHIC 118473
7 GRAPHIC g116321bei006.jpg GRAPHIC 133589
8 GRAPHIC g116321bei007.jpg GRAPHIC 42539
  Complete submission text file 0001104659-17-025044.txt   1061209
Mailing Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036
Business Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036 212-969-3335
Grifols SA (Filer) CIK: 0001438569 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35193 | Film No.: 17774226
SIC: 2834 Pharmaceutical Preparations